ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.

Carmine De Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.